Virtual Screening in Drug Design and Development

被引:0
|
作者
Sousa, Sergio F. [1 ]
Cerqueira, Nuno M. F. S. A. [1 ]
Fernandes, Pedro A. [1 ]
Ramos, Maria Joao [1 ]
机构
[1] Univ Porto, REQUIMTE, Dept Quim, Fac Ciencias, P-4169007 Oporto, Portugal
关键词
Drug design; docking; scoring; filters; compound libraries; druggability; protein flexibility; computational chemistry; PROTEIN-COUPLED RECEPTORS; MOLECULAR DOCKING; CHEMICAL DATABASES; LEAD OPTIMIZATION; LIGAND DOCKING; DISCOVERY; FLEXIBILITY; STRATEGIES; INHIBITORS; BETA;
D O I
暂无
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Virtual screening (VS) is presently a key component in the process of drug design and development. VS is normally regarded as the selection of likely drug candidates from large libraries of chemical structures by using computational methodologies. However, the generic definition of VS is significantly wider and may encompass many different methods. This review tries to present a comprehensive overview of the virtual screening process and of its importance in the present drug discovery and development paradigm. Following a focused contextualization on the subject, an introduction to the general types of virtual screening methodologies is presented. The main stages of a virtual screening campaign, including its strengths and limitations, are the subject of particular attention in this review. This analysis is complemented with a careful selection of VS success stories. Finally, a reflection on the future challenges of this promising methodology is drawn.
引用
收藏
页码:442 / 453
页数:12
相关论文
共 50 条
  • [1] Development of Xsi, An Integrated Environment for Virtual Screening and Drug Design
    Inagaki, Yuichiro
    [J]. JOURNAL OF COMPUTER CHEMISTRY-JAPAN, 2005, 4 (04) : 197 - 202
  • [2] Virtual Screening Strategies in Drug Design
    Rodrigues, Ricardo P.
    Mantoani, Susimaire P.
    de Almeida, Jonathan R.
    Pinsetta, Flavio Roberto
    Semighini, Evandro P.
    da Silva, Vinicius B.
    da Silva, Carlos Henrique T. P.
    [J]. REVISTA VIRTUAL DE QUIMICA, 2012, 4 (06) : 739 - 776
  • [3] Drug Design by Pharmacophore and Virtual Screening Approach
    Giordano, Deborah
    Biancaniello, Carmen
    Argenio, Maria Antonia
    Facchiano, Angelo
    [J]. PHARMACEUTICALS, 2022, 15 (05)
  • [4] Virtual Screening and Structure Generation Applied to Drug Design
    FAN B.T.
    A. PANAYE
    J-P. DOUCET
    [J]. 合成化学, 2004, (S1) : 14 - 14
  • [5] Advances in structure based drug design and virtual screening
    Abagyan, Ruben
    [J]. FASEB JOURNAL, 2008, 22
  • [6] Hierarchical structure-based virtual screening for drug design
    Miteva, M.
    [J]. BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT, 2008, 22 (01) : 634 - 638
  • [7] Virtual screening and its integration with modern drug design technologies
    Guido, Rafael V. C.
    Oliva, Glaucius
    Andricopulo, Adriano D.
    [J]. CURRENT MEDICINAL CHEMISTRY, 2008, 15 (01) : 37 - 46
  • [8] Structure-based approaches to drug design and virtual screening
    Waszkowycz, B
    [J]. CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2002, 5 (03) : 407 - 413
  • [9] Virtual Screening of Drugs: Score Functions, Docking, and Drug Design
    Breda, Ardala
    Basso, Luiz A.
    Santos, Diogenes S.
    de Azevedo, Walter F., Jr.
    [J]. CURRENT COMPUTER-AIDED DRUG DESIGN, 2008, 4 (04) : 265 - 272
  • [10] Virtual screening and de novo drug design with machine learning
    Parks, Conor
    Gaieb, Zied
    Amaro, Rommie
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 258